Status:
COMPLETED
Evaluating the Effectiveness of Piscean Derived Collagen Dressing on Neuropathic Diabetic Foot Ulcer in T2DM Patients
Lead Sponsor:
Corporacion Parc Tauli
Conditions:
Diabetic Foot Ulcer Neuropathic
Diabetic Foot Ulcer
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
Diabetic foot ulcers (DFU) are challenging to treat with complicated healing processes and require advanced wound care. Piscean collagen has the potential to promote the regenerative process while rem...
Detailed Description
Diabetic foot ulcers (DFU) are challenging to treat with complicated healing processes and require advanced wound care. Piscean collagen has the potential to promote the regenerative process while rem...
Eligibility Criteria
Inclusion
- patients with neuropathic DFUs at Grades I or II for a period of at least 12 weeks, based on the Wagner classification;
- be able to understand simple instructions and provided voluntary, signed informed consent.
Exclusion
- active infection which might lead to hospitalisation, gangrene,
- systemic inflammatory or autoimmune disease
- renal failure
- presence of ischaemia or osteomyelitis
Key Trial Info
Start Date :
December 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT05324930
Start Date
December 2 2021
End Date
September 1 2022
Last Update
November 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zainab Khan
Lahore, Punjab Province, Pakistan